Identification of Fixed Asset Impairment Indicators and Testing Disclosure Pre-IPO

The HKEX Listing Division’s 2024 annual review of listing decisions identified fixed asset impairment as the second-most common accounting adjustment required in pre-IPO vetting, trailing only revenue recognition. This finding, published in the HKEX’s Listing Review Report 2024 (January 2025), signals a material escalation in the Exchange’s scrutiny of non-current asset valuations during the listing process. For applicants filing A1 submissions in 2025-2026, the consequence is direct: the Listing Division now routinely requires pre-IPO impairment testing to be completed and disclosed in the Accountants’ Report, not merely referenced as a post-listing policy. The shift is grounded in HKEX Listing Rules Chapter 9, Rule 9.11(24a), which mandates that a listing applicant’s accountants’ report must present a true and fair view of financial position — a standard the Division interprets as requiring explicit identification of impairment indicators and quantitative testing results for each material class of fixed assets. This article examines the regulatory mechanics of that requirement, the testing methodologies the Exchange expects, and the disclosure benchmarks that sponsors and reporting accountants must meet to avoid a return of the A1 application.

The Regulatory Framework for Pre-IPO Impairment

HKEX Listing Rules Chapter 9 and the Accountants’ Report Mandate

HKEX Listing Rules Chapter 9, Rule 9.11(24a) requires that an applicant’s accountants’ report, prepared in accordance with Hong Kong Financial Reporting Standards (HKFRS) or equivalent, must cover a track record period of at least three complete financial years. Under HKFRS, specifically HKAS 36 Impairment of Assets, an entity must assess at each reporting date whether there is any indication that an asset may be impaired. The HKEX Listing Division, in its Listing Decision LD43-3 (2013, reaffirmed 2023), clarified that this assessment is not a post-listing compliance matter but a pre-IPO disclosure requirement. The Division expects the reporting accountant to identify and disclose all impairment indicators present during the track record period, and to perform the corresponding impairment testing — including recoverable amount calculations — for any assets where indicators exist.

The practical implication for applicants is that a mere statement in the prospectus that “management will review impairment indicators annually” is insufficient. The HKEX requires the actual testing results, including the recoverable amount (the higher of fair value less costs of disposal and value in use), to be quantified and disclosed in the Accountants’ Report section of the prospectus. This requirement applies to all fixed asset classes: property, plant and equipment (PPE), right-of-use assets under HKFRS 16 Leases, and investment properties carried at cost.

The SFC’s Code of Conduct and Sponsor Obligations

The Securities and Futures Commission (SFC) Code of Conduct for Persons Licensed by or Registered with the Securities and Futures Commission (Chapter 571, subsidiary legislation), paragraph 17.6, imposes a sponsor’s duty of reasonable due diligence. In the context of fixed asset impairment, this means the sponsor must independently verify the applicant’s impairment indicators identification and testing methodology. The SFC’s Sponsor Supervision Review Report 2023 (published December 2023) cited two enforcement cases where sponsors failed to challenge management’s conclusion that no impairment indicators existed, despite clear external evidence such as declining market rents for industrial properties or regulatory changes affecting plant utilisation. The SFC’s position is clear: the sponsor cannot rely solely on management’s representation; it must perform its own assessment of external and internal impairment indicators, as defined in HKAS 36 paragraphs 12-14.

Identifying Impairment Indicators: External and Internal Sources

External Indicators and Market Evidence

HKAS 36 paragraph 12 lists external sources of impairment indicators, including significant declines in market value, adverse changes in the technological, market, economic, or legal environment, and increases in market interest rates affecting the discount rate used in value-in-use calculations. For a pre-IPO applicant, the most common external indicator is a sustained decline in the market value of a fixed asset class — for example, industrial property in a manufacturing company where the local government has imposed stricter emission standards, reducing the asset’s productive capacity. The HKEX requires that the applicant quantify the decline, citing specific market indices or independent valuation reports.

A 2024 case study from the HKEX’s Listing Decisions Compendium (Case LD-2024-07) involved a manufacturing applicant whose factory machinery had a carrying amount of HKD 85 million. The applicant’s prospectus disclosed that the machinery was used to produce a product line that had been banned by the PRC Ministry of Ecology and Environment in 2023. The HKEX required the applicant to perform an impairment test, resulting in an impairment loss of HKD 32 million. The Exchange’s rationale was that the regulatory change constituted an external indicator under HKAS 36 paragraph 12(b) — an “adverse change in the legal environment” — and the applicant had failed to identify it in its initial A1 submission.

Internal Indicators and Operational Triggers

Internal indicators under HKAS 36 paragraph 12 include evidence of obsolescence or physical damage, significant adverse changes in the extent or manner of use of the asset, and economic performance of the asset being worse than expected. For a pre-IPO applicant, the most frequently overlooked internal indicator is a change in the asset’s utilisation rate. The HKEX’s Listing Review Report 2024 noted that in 2023, 12 of 18 A1 applications returned for additional financial information involved fixed asset impairment issues, of which 8 cases were triggered by utilisation rates falling below 60% of installed capacity for two consecutive years.

The reporting accountant must document the utilisation rate for each material class of PPE and compare it to the budgeted or industry-average rate. Where utilisation is materially lower, the accountant must test for impairment using the value-in-use approach, which requires projecting future cash flows from the asset’s use and discounting them at a pre-tax rate reflecting current market assessments of the time value of money and the asset’s specific risks (HKAS 36 paragraph 55). The HKEX expects the disclosure to include the key assumptions used — revenue growth rate, terminal growth rate, and discount rate — and a sensitivity analysis showing the impact of a 1% change in the discount rate on the recoverable amount.

Testing Methodology and Recoverable Amount Calculation

Fair Value Less Costs of Disposal (FVLCD) Approach

For assets with an active market — such as listed property, plant, or equipment with observable market prices — the HKEX expects the applicant to use the fair value less costs of disposal (FVLCD) approach as the primary method for determining recoverable amount. This approach requires an independent valuation by a qualified valuer, typically a member of the Hong Kong Institute of Surveyors (HKIS) or the Royal Institution of Chartered Surveyors (RICS). The valuation must be performed in accordance with the HKIS Valuation Standards (2024 edition) and must disclose the valuation method (market comparison, income capitalisation, or depreciated replacement cost) and the key assumptions.

The reporting accountant must then reconcile the valuation result to the asset’s carrying amount. If the FVLCD is lower than the carrying amount, an impairment loss is recognised. The HKEX’s Listing Decision LD43-3 specifically requires that the valuation report be included in the prospectus as a material contract or be summarised in the Accountants’ Report section. In practice, the HKEX Listing Division expects the valuation to be dated no more than six months before the date of the prospectus.

Value in Use (VIU) Approach and Cash Flow Projections

Where no active market exists — for example, specialised manufacturing equipment or custom-built facilities — the value-in-use (VIU) approach is the appropriate method. The VIU calculation under HKAS 36 paragraph 30 requires the applicant to project cash inflows and outflows from the asset’s continuing use, including its eventual disposal. The HKEX expects the projection period to be limited to the asset’s remaining useful life, not exceeding five years unless a longer period can be justified. The discount rate used must be a pre-tax rate that reflects the asset’s specific risks, not the company’s weighted average cost of capital (WACC) unless the WACC has been adjusted for asset-specific risk.

A 2025 enforcement case from the SFC’s Enforcement Bulletin (Issue 78, March 2025) involved a logistics company applicant whose VIU calculation for warehouse assets used a post-tax discount rate of 8.5% without adjusting for the asset’s specific risk. The SFC found that the correct pre-tax rate should have been 11.2%, resulting in a recoverable amount HKD 45 million lower than the carrying amount. The sponsor was fined HKD 12 million for failing to identify this error during due diligence. The lesson for applicants is that the discount rate must be explicitly justified, and the reporting accountant must include a reconciliation of the pre-tax rate to the company’s WACC.

Sensitivity Analysis and Disclosure Requirements

The HKEX’s Listing Decision LD43-3 requires that the prospectus disclose a sensitivity analysis for the key assumptions used in the impairment test. This analysis must show the impact on the recoverable amount of a 1% increase or decrease in the discount rate, a 1% change in the revenue growth rate, and a 10% change in the terminal value. The analysis must be presented in tabular format within the Accountants’ Report, alongside the base-case recoverable amount and the resulting impairment loss or headroom.

For applicants with multiple fixed asset classes, the HKEX expects the disclosure to be disaggregated by class and by geographical segment, consistent with HKFRS 8 Operating Segments. A 2024 review of prospectuses filed on the Main Board showed that 28 of 45 applicants included a sensitivity analysis that met the HKEX’s minimum standard, while 17 were required to supplement their disclosure during the comment letter process. The most common deficiency was the failure to disclose the terminal growth rate assumption, which the HKEX considers a material input.

Disclosure in the Prospectus and Accountants’ Report

Structuring the Accountants’ Report Section

The Accountants’ Report must include a dedicated section on fixed asset impairment, typically under “Critical Accounting Judgements and Key Sources of Estimation Uncertainty” (HKAS 1 paragraph 125). This section must identify each material class of fixed assets, state whether impairment indicators were present during each year of the track record period, and disclose the recoverable amount for each class where testing was performed. The HKEX expects the disclosure to be presented in a comparative format — showing the carrying amount, recoverable amount, and impairment loss for each of the three years in the track record period.

The reporting accountant must also disclose the method used to determine recoverable amount (FVLCD or VIU) and the key assumptions for each method. For FVLCD, the disclosure must include the valuation date, the valuer’s name and qualifications, and the valuation approach. For VIU, the disclosure must include the projection period, the pre-tax discount rate, the revenue growth rate, and the terminal growth rate. The HKEX’s Listing Decision LD43-3 explicitly states that the disclosure must be “sufficiently detailed to enable a prospective investor to understand the degree of estimation uncertainty involved.”

The Sponsor’s Role in Disclosure Review

The sponsor must review the impairment disclosure for consistency with the underlying testing results and with other sections of the prospectus. The SFC’s Code of Conduct paragraph 17.6(c) requires the sponsor to ensure that the prospectus does not contain any untrue statement of material fact. In the context of fixed asset impairment, this means the sponsor must verify that the impairment loss recognised in the Accountants’ Report is consistent with the impairment charge in the income statement and the carrying amount in the statement of financial position.

A common issue identified by the HKEX in 2024 was the mismatch between impairment loss recognised in the Accountants’ Report and the amount disclosed in the “Financial Summary” section of the prospectus. In one case, an applicant recognised an impairment loss of HKD 18 million in the Accountants’ Report but disclosed HKD 12 million in the summary, leading to a comment letter requiring correction. The sponsor’s due diligence must include a line-by-line reconciliation of the impairment figures across all sections of the prospectus.

Actionable Takeaways

1. Pre-IPO applicants must perform a full HKAS 36 impairment test for each material class of fixed assets during each year of the track record period, not merely at the date of the prospectus, and disclose the results in the Accountants’ Report.
2. The sponsor must independently verify the identification of impairment indicators against external market data and internal operational metrics, including utilisation rates, and document this verification in the due diligence work papers.
3. The recoverable amount calculation must use a pre-tax discount rate specific to the asset class, not the company’s WACC, and the reporting accountant must disclose the reconciliation between the two rates.
4. The prospectus must include a sensitivity analysis for each key assumption used in the impairment test, presented in tabular format, showing the impact of a 1% change in the discount rate and growth rates on the recoverable amount.
5. The impairment disclosure must be consistent across the Accountants’ Report, the Financial Summary, and the notes to the financial statements, and the sponsor must perform a line-by-line reconciliation to avoid comment letters from the HKEX Listing Division.